MTOR and hyperlipidemia: Taking together, in hyperlipidemia status, the IL-35–promoted ApoE–/– CCR5+ Tregs exhibit a lower Akt/mTOR activation, suggesting that IL-35 may play a vital role in maintaining a stable Treg immunosuppressive signature in hyperlipidemia (82).